Giovanna Lopes Carvalho

Giovanna Lopes Carvalho

Auto-generated profile, based on publicly available information

Giovanna Lopes Carvalho

Department of Stomatology, Discipline of Oral and Maxillofacial Pathology School of Dentistry, University of São Paulo São Paulo São Paulo Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SMStella Moreira
Stella Moreira
GSGiovanna Sarra
Giovanna Sarra
GCGiovanna Lopes Carvalho
Giovanna Lopes Carvalho
FGFlavia Goncalves
Flavia Goncalves
HCHector Valentin Caballero-Flores
Hector Valentin Caballero-Flores
MMMarques Martins Marques
Marques Martins Marques
Background. The regeneration of dental pulp, especially in cases of pulp death of immature teeth, is the goal of the regenerative endodontic procedures (REPs) that are based on tissue engineering principles, consisting of stem cells, growth factors, and scaffolds. Photobiomodulation therapy (PBMT) showed to improve dental pulp regeneration through cell homing approaches in preclinical studies and has been proposed as the fourth element of tissue engineering. However, when a blood clot was used as a scaffold in one of these previous studies, only 30% of success was achieved. The authors pointed out the instability of the blood clot as the regeneration shortcoming. Then, to circumvent this problem, a new scaffold was developed to be applied with the blood clot. The hypothesis of the present study was that an experimental injectable chitosan hydrogel would facilitate the three‐dimensional spatial organization of endogenous stem cells in dental pulp regeneration with no interference on the positive influence of PBMT. Methods. For the in vitro analysis, stem cells from the apical papilla (SCAPs) were characterized by flow cytometry and applied in the chitosan scaffold for evaluating adhesion, migration, and proliferation. For the in vivo analysis, the chitosan scaffold was applied in a rodent orthotopic dental pulp regeneration model under the influence of PBMT (660 nm; power output of 20 mW, beam area of 0.028 cm2, and energy density of 5 J/cm2). Results. The scaffold tested in this study allowed significantly higher viability, proliferation, and migration of SCAPs in vitro when PBMT was applied, especially with the energy density of 5 J/cm2. These results were in consonance to those of the in vivo data, where pulp‐like tissue formation was observed inside the root canal. Conclusion. Chitosan hydrogel when applied with a blood clot and PBMT could in the future improve previous results of dental pulp regeneration through cell homing approaches.

1 September 2021 in Archives of Oral Biology
Verified
Journal Article
Closed access
FMFabiana Divina Magalhães
Fabiana Divina Magalhães
GSGiovanna Sarra
Giovanna Sarra
GCGiovanna Lopes Carvalho
Giovanna Lopes Carvalho
APAna Clara Fagundes Pedroni
Ana Clara Fagundes Pedroni
MMMárcia Martins Marques
Márcia Martins Marques
SMStella Moreira
Stella Moreira

4 March 2022 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
GCGiovanna Lopes Carvalho
Giovanna Lopes Carvalho
GSGiovanna Sarra
Giovanna Sarra
GSGabriella Torres Schröter
Gabriella Torres Schröter
LSLinda Sarah Reis Gomes Silva
Linda Sarah Reis Gomes Silva
SASuely Kunimi Kubo Ariga
Suely Kunimi Kubo Ariga
MMMaria Stella Moreira
Maria Stella Moreira

3 August 2023 in Special Care in Dentistry
Verified
Journal Article
Closed access
GSGabriella Torres Schroter
Gabriella Torres Schroter
RSRenata Maria Mamprin Stopiglia
Renata Maria Mamprin Stopiglia
GCGiovanna Lopes Carvalho
Giovanna Lopes Carvalho
SMSusana Morimoto
Susana Morimoto
MMMaria Emília Mota
Maria Emília Mota
SMStella Moreira
Stella Moreira

8 July 2025 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Open access
JSJuliana Mota Siqueira
Juliana Mota Siqueira
YMYoshitsugu Mitani
Yoshitsugu Mitani
MMMario L. Marques-Piubelli
Mario L. Marques-Piubelli
CHCamilla Oliveira Hoff
Camilla Oliveira Hoff
FBFlavia Bonini
Flavia Bonini
RFRenata Ferrarotto
Renata Ferrarotto
Background: Adenoid cystic carcinoma (ACC) is a common salivary gland carcinoma with high recurrence and distant metastasis rates. Currently, there is no standard systemic treatment available. TROP2 is a transmembrane glycoprotein involved in the oncogenesis of several tumors that can be therapeutically targeted by a TROP2‐antibody–drug conjugate (ADC). We aimed to characterize TROP2 expression in ACC and assess TROP2 as a potential therapeutic target.Methods: TROP2 immunohistochemistry was performed in a tissue microarray including 165 ACC of salivary gland. The tumors were grouped according to the histological pattern as non‐solid, solid + non‐solid, or solid. TROP2 protein expression in ACC cell lines was assessed and subjected to drug screening with TROP2‐ADC.Results: TROP2 expression was high in 59%, moderate in 30%, weak in 8%, and negative in 3% of cases. TROP2 expression was significantly higher in non‐solid compared with solid or solid + non‐solid (p < 0.001). Notably, TROP2 expression was heterogenous among the dual cellular component, with TROP2 expression identified predominantly in the ductal and not in the myoepithelial cells. In vitro drug screening demonstrated that TROP2‐ADC had selective anti‐tumor effect in TROP2 expressing ACC cells.Conclusions: TROP2 expression is prevalent in ACC, particularly in the ductal cell component of the non‐solid tumors. The pre‐clinical drug screening findings provide a biological rationale for exploring TROP2 as a therapeutic target in TROP2‐expressing ACC.Trial Registration: clinicaltrials.gov: NCT05884320; NCI‐2023‐04260